Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa

References

• Aires, J. R., Pechère, J.-C., Van Delden, C., & Köhler, T. (2002). Amino acid residues essential for function of the MexF efflux pump protein of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 46(7), 2169–2173.10.1128/AAC.46.7.2169-2173.2002
   PubMed Web of Science ®Google Scholar
• Aygül, A. (2015). The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance. Mikrobiyoloji Bülteni, 49(2), 278–291.10.5578/mb.8964
   PubMed Web of Science ®Google Scholar
• Cabot, G., Ocampo-Sosa, A. A., Tubau, F., Macia, M. D., Rodríguez, C., Moya, B., … Spanish Network for Research in Infectious Diseases (REIPI). (2011). Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: Prevalence and impact on resistance in a Spanish multicenter study. Antimicrobial Agents and Chemotherapy, 55(5), 1906–1911. doi:10.1128/AAC.01645-10
   PubMed Web of Science ®Google Scholar
• Catry, B., Cavaleri, M., Baptiste, K., Grave, K., Grein, K., Holm, A., … Edo, J. T. (2015). Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): Development of resistance in animals and possible impact on human and animal health. International Journal of Antimicrobial Agents, 46(3), 297–306. doi:10.1016/j.ijantimicag.2015.06.005
   PubMed Web of Science ®Google Scholar
• Cellular Gatekeepers. (2016). Focus on membrane proteins. Nature Structural & Molecular Biology, 23(6), 464. doi:10.1038/nsmb.3246
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. (2015). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically – Tenth edition: Approved standard M07-A10. Author.
   Google Scholar
• Collu, F., & Cascella, M. (2013). Multidrug resistance and efflux pumps: Insights from molecular dynamics simulations. Current Topics in Medicinal Chemistry, 13(24), 3165–3183.10.2174/15680266113136660224
   PubMed Web of Science ®Google Scholar
• De Kievit, T. R., Parkins, M. D., Gillis, R. J., Srikumar, R., Ceri, H., Poole, K., … Storey, D. G. (2001). Multidrug efflux pumps: Expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrobial Agents and Chemotherapy, 45(6), 1761–1770. doi:10.1128/AAC.45.6.1761-1770.2001
   PubMed Web of Science ®Google Scholar
• Denisov, I. G., & Sligar, S. G. (2016). Nanodiscs for structural and functional studies of membrane proteins. Nature Structural & Molecular Biology, 23(6), 481–486. doi:10.1038/nsmb.3195
   PubMed Web of Science ®Google Scholar
• Dixon, R. E., & Centers for Disease Control and Prevention (CDC). (2011). Control of health-care-associated infections, 1961–2011. Morbidity and Mortality Weekly Report. Surveillance Summaries, 60(Suppl 4), 58–63.
   Google Scholar
• Draenert, R., Seybold, U., Grützner, E., & Bogner, J. R. (2015). Novel antibiotics: Are we still in the pre–post-antibiotic era? Infection, 43(2), 145–151. doi:10.1007/s15010-015-0749-y
   PubMed Web of Science ®Google Scholar
• Dwivedi, G. R., Gangwar, B., Gupta, M. K., Gupta, P., Singh, Devendra P., Verma, S. K., & Darokar, M. P. (2017). Determination of MDR mechanisms of P. aeruginosa clinical isolates. EC Microbiology, 5(6), 241–247.
   Google Scholar
• Dwivedi, G. R., Gupta, S., Maurya, A., Tripathi, S., Sharma, A., Darokar, M. P., & Srivastava, S. K. (2015). Synergy potential of indole alkaloids and its derivative against drug-resistant Escherichia coli. Chemical Biology & Drug Design, 86(6), 1471–1481. doi:10.1111/cbdd.12613
   PubMed Web of Science ®Google Scholar
• Dwivedi, G. R., Gupta, S., Roy, S., Kalani, K., Pal, A., Thakur, J. P., … Srivastava, S. K. (2013). Tricyclic sesquiterpenes from Vetiveria zizanoides (L.) nash as antimycobacterial agents. Chemical Biology & Drug Design, 82(5), 587–594. doi:10.1111/cbdd.12188
   PubMed Web of Science ®Google Scholar
• Dwivedi, G. R., Maurya, A., Yadav, D. K., Khan, F., Darokar, M. P., & Srivastava, S. K. (2015). Drug resistance reversal potential of ursolic acid derivatives against nalidixic acid- and multidrug-resistant Escherichia coli. Chemical Biology & Drug Design, 86(3), 272–283. doi:10.1111/cbdd.12491
   PubMed Web of Science ®Google Scholar
• Dwivedi, G. R., Sanchita, G., Singh, D. P., Sharma, A., Darokar, M. P., & Srivastava, S. K. (2016). Nano particles: Emerging warheads against bacterial superbugs. Current Topics in Medicinal Chemistry, 16(18), 1963–1975.10.2174/1568026616666160215154556
   PubMed Web of Science ®Google Scholar
• Dwivedi, G. R., Tiwari, N., Singh, A., Kumar, A., Roy, S., Negi, A. S., … Darokar, M. P. (2016). Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli. Applied Microbiology and Biotechnology, 100(5), 2311–2325. doi:10.1007/s00253-015-7152-6
   PubMed Web of Science ®Google Scholar
• Dwivedi, G. R., Upadhyay, H. C., Yadav, D. K., Singh, V., Srivastava, S. K., Khan, F., … Darokar, M. P. (2014). 4-Hydroxy-α-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli. Chemical Biology & Drug Design, 83(4), 482–492. doi:10.1111/cbdd.12263
   PubMed Web of Science ®Google Scholar
• El Zowalaty, M. E., Al Thani, A. A., Webster, T. J., El Zowalaty, A. E., Schweizer, H. P., Nasrallah, G. K., … Ashour, H. M. (2015). Pseudomonas aeruginosa: Arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies. Future Microbiology, 10, 1683–1706. doi:10.2217/fmb.15.48
   PubMed Web of Science ®Google Scholar
• Eliopoulos, G. M., & Moellering, R. C. J. (1996). Antimicrobial combinations. In Antibiotics in laboratory medicine (4th ed., pp. 330–336). Baltimore, MD: Williams & Wilkins.
   Google Scholar
• Eliopoulos, G. M., & Wennersten, C. B. (2002). Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy, 46(5), 1319–1324.10.1128/AAC.46.5.1319-1324.2002
   PubMed Web of Science ®Google Scholar
• Fong, J. H., & Marchler-Bauer, A. (2008). Protein subfamily assignment using the conserved domain database. BMC Research Notes, 1(1), 114. doi:10.1186/1756-0500-1-114
   PubMedGoogle Scholar
• Giske, C. G., Buarø, L., Sundsfjord, A., & Wretlind, B. (2008). Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa. Microbial Drug Resistance, 14(1), 23–30. doi:10.1089/mdr.2008.0778
   PubMed Web of Science ®Google Scholar
• Goodsell, D. S., Morris, G. M., & Olson, A. J. (1996). Automated docking of flexible ligands: Applications of autodock. Journal of Molecular Recognition: JMR, 9(1), 1–5. doi:10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6
   PubMed Web of Science ®Google Scholar
• Gould, I. M. (2009). Antibiotic resistance: The perfect storm. International Journal of Antimicrobial Agents, 34(Suppl 3), S2–S5. doi:10.1016/S0924-8579(09)70549-7
   PubMedGoogle Scholar
• Grgurich, P. E., Hudcova, J., Lei, Y., Sarwar, A., & Craven, D. E. (2012). Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens. Expert Review of Respiratory Medicine, 6(5), 533–555. doi:10.1586/ers.12.45
   PubMed Web of Science ®Google Scholar
• Handzlik, J., Matys, A., & Kieć-kononowicz, K. (2013). Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of gram-positive bacteria S. aureus. Antibiotics, 2, 28–45. doi:10.3390/antibiotics2010028
   Google Scholar
• Heisig, P., & Tschorny, R. (1994). Characterization of fluoroquinolone-resistant mutants of Escherichia coli selected in vitro. Antimicrobial Agents and Chemotherapy, 38(6), 1284–1291.10.1128/AAC.38.6.1284
   PubMed Web of Science ®Google Scholar
• Hevener, K. E., Cao, S., Zhu, T., Su, P.-C., Mehboob, S., & Johnson, M. E. (2013). Special challenges to the rational design of antibacterial agents. In Annual reports in medicinal chemistry (pp. 283–298). Elsevier. Retrieved from http://linkinghub.elsevier.com/retrieve/pii/B9780124171503000181
   Web of Science ®Google Scholar
• Higgins, M. K., Bokma, E., Koronakis, E., Hughes, C., & Koronakis, V. (2004). Structure of the periplasmic component of a bacterial drug efflux pump. Proceedings of the National Academy of Sciences, 101(27), 9994–9999. doi:10.1073/pnas.0400375101
   PubMed Web of Science ®Google Scholar
• Infectious Diseases Society of America. (2010). The 10 × ‘20 initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 50(8), 1081–1083. doi:10.1086/652237
   PubMed Web of Science ®Google Scholar
• Jones, K. E., Patel, N. G., Levy, M. A., Storeygard, A., Balk, D., Gittleman, J. L., & Daszak, P. (2008). Global trends in emerging infectious diseases. Nature, 451(7181), 990–993. doi:10.1038/nature06536
   PubMed Web of Science ®Google Scholar
• Khan, I. A., Mirza, Z. M., Kumar, A., Verma, V., & Qazi, G. N. (2006). Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 50(2), 810–812. doi:10.1128/AAC.50.2.810-812.2006
   PubMed Web of Science ®Google Scholar
• Kulshin, V. A., Zähringer, U., Lindner, B., Jäger, K. E., Dmitriev, B. A., & Rietschel, E. T. (1991). Structural characterization of the lipid A component of Pseudomonas aeruginosa wild-type and rough mutant lipopolysaccharides. European Journal of Biochemistry/FEBS, 198(3), 697–704.10.1111/ejb.1991.198.issue-3
   PubMedGoogle Scholar
• Kumar, A., Khan, I. A., Koul, S., Koul, J. L., Taneja, C., Ali, I., & Qazi, G. N. (2008). Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus, 61(6), 1270–1276. doi:10.1093/jac/dkn088
   Google Scholar
• Lamers, R. P., Cavallari, J. F., & Burrows, L. L. (2013). The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria. PLoS ONE, 8(3), e60666. doi:10.1371/journal.pone.0060666
   PubMed Web of Science ®Google Scholar
• Li, X.-Z., Plésiat, P., & Nikaido, H. (2015). The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria. Clinical Microbiology Reviews, 28(2), 337–418. doi:10.1128/CMR.00117-14
   PubMed Web of Science ®Google Scholar
• Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., … Lewis, K. (2015). A new antibiotic kills pathogens without detectable resistance. Nature, 517(7535), 455–459. doi:10.1038/nature14098
   PubMed Web of Science ®Google Scholar
• Lomovskaya, O., & Watkins, W. J. (2001). Efflux pumps: Their role in antibacterial drug discovery. Current Medicinal Chemistry, 8(14), 1699–1711.10.2174/0929867013371743
   PubMed Web of Science ®Google Scholar
• Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., … Lee, V. J. (2001). Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy. Antimicrobial Agents and Chemotherapy, 45(1), 105–116. doi:10.1128/AAC.45.1.105-116.2001
   PubMed Web of Science ®Google Scholar
• Marchler-Bauer, A., Lu, S., Anderson, J. B., Chitsaz, F., Derbyshire, M. K., DeWeese-Scott, C., … Bryant, S. H. (2011). CDD: A conserved domain database for the functional annotation of proteins. Nucleic Acids Research, 39(Database), 225–229. doi:10.1093/nar/gkq1189
   PubMed Web of Science ®Google Scholar
• Maroyi, A. (2013). Traditional use of medicinal plants in south-central Zimbabwe: Review and perspectives. Journal of Ethnobiology and Ethnomedicine, 9(1), 31. doi:10.1186/1746-4269-9-31
   PubMed Web of Science ®Google Scholar
• Martens, E., & Demain, A. L. (2017). The antibiotic resistance crisis, with a focus on the United States. The Journal of Antibiotics, 70(5), 520–526. doi:10.1038/ja.2017.30
   PubMed Web of Science ®Google Scholar
• Martins, M., Couto, I., Viveiros, M., & Amaral, L. (2010). Identification of efflux-mediated multi-drug resistance in bacterial clinical isolates by two simple methods. In S. H. Gillespie & T. D. McHugh (Eds.), Antibiotic resistance protocols, Vol. 642 (pp. 143–157). Totowa, NJ: Humana Press . Retrieved from http://link.springer.com/10.1007/978-1-60327-279-7_11.10.1007/978-1-60327-279-7
   Google Scholar
• Meletis, G. (2016). Carbapenem resistance: Overview of the problem and future perspectives. Therapeutic Advances in Infectious Disease, 3(1), 15–21. doi:10.1177/2049936115621709
   PubMed Web of Science ®Google Scholar
• Moisan, L., Comesse, S., Giovanelli, E., Rousseau, B., & Doris, E.. (2012). Fluorinated catharanthine derivatives, their preparation and their utilisation as vinca dimeric alkaloid precursors. US 8,101,748 B2.
   Google Scholar
• Monlezun, L., Phan, G., Benabdelhak, H., Lascombe, M.-B., Enguéné, V. Y. N., Picard, M., & Broutin, I. (2015). New OprM structure highlighting the nature of the N-terminal anchor. Frontiers in Microbiology, 6, 667. doi:10.3389/fmicb.2015.00667
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. doi:10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Web of Science ®Google Scholar
• Nakashima, R., Sakurai, K., Yamasaki, S., Hayashi, K., Nagata, C., Hoshino, K., … Yamaguchi, A. (2013). Structural basis for the inhibition of bacterial multidrug exporters. Nature, 500(7460), 102–106. doi:10.1038/nature12300
   PubMed Web of Science ®Google Scholar
• Nikaido, H. (2003). Molecular basis of bacterial outer membrane permeability revisited. Microbiology and Molecular Biology Reviews: MMBR, 67(4), 593–656.10.1128/MMBR.67.4.593-656.2003
   PubMed Web of Science ®Google Scholar
• Nikaido, H. (2009). Multidrug resistance in bacteria. Annual Review of Biochemistry, 78, 119–146. doi:10.1146/annurev.biochem.78.082907.145923
   PubMed Web of Science ®Google Scholar
• Odds, F. C. (2003). Synergy, antagonism, and what the chequerboard puts between them. The Journal of Antimicrobial Chemotherapy, 52(1), 1. doi:10.1093/jac/dkg301
   PubMed Web of Science ®Google Scholar
• Pagès, J.-M., & Amaral, L. (2009). Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria. Biochimica Et Biophysica Acta, 1794(5), 826–833. doi:10.1016/j.bbapap.2008.12.011
   PubMed Web of Science ®Google Scholar
• Parkins, M. D., & Floto, R. A. (2015). Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 14(3), 293–304. doi:10.1016/j.jcf.2015.03.012
   PubMed Web of Science ®Google Scholar
• Piddock, L. J. V. (2015). Teixobactin, the first of a new class of antibiotics discovered by iChip technology? The Journal of Antimicrobial Chemotherapy, 70(10), 2679–2680. doi:10.1093/jac/dkv175
   PubMed Web of Science ®Google Scholar
• Poole, K. (2001). Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. Journal of Molecular Microbiology and Biotechnology, 3(2), 255–264.
   PubMed Web of Science ®Google Scholar
• Renau, T. E., Léger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R., … Nakayama, K. (1999). Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. Journal of Medicinal Chemistry, 42(24), 4928–4931.10.1021/jm9904598
   PubMed Web of Science ®Google Scholar
• Roberts, L., & Simpson, S. (2008). Drug resistance. Deadly defiance. Introduction to special issue. Science, 321(5887), 355. doi:10.1126/science.321.5887.355
   PubMed Web of Science ®Google Scholar
• Ruggerone, P., Vargiu, A. V., Collu, F., Fischer, N., & Kandt, C. (2013). Molecular dynamics computer simulations of multidrug RND efflux pumps. Computational and Structural Biotechnology Journal, 5(6), 1–11. doi:10.5936/csbj.201302008
   Google Scholar
• Ruppé, É., Woerther, P.-L., & Barbier, F. (2015). Mechanisms of antimicrobial resistance in Gram-negative bacilli. Annals of Intensive Care, 5(1), 1–15. doi:10.1186/s13613-015-0061-0
   PubMed Web of Science ®Google Scholar
• Sana, T. G., & Monack, D. M. (2016). Microbiology: The dark side of antibiotics. Nature, 534(6), 624–625. doi:10.1038/nature18449
   PubMed Web of Science ®Google Scholar
• Sanner, M. F. (1999). Python: A programming language for software integration and development. Journal of Molecular Graphics & Modelling, 17(1), 57–61.
   PubMed Web of Science ®Google Scholar
• Spellberg, B., & Gilbert, D. N. (2014). The future of antibiotics and resistance: A tribute to a career of leadership by John Bartlett. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 59(Suppl 2), S71–S75. doi:10.1093/cid/ciu392
   PubMed Web of Science ®Google Scholar
• Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000). Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 97(4), 1433–1437. doi:10.1073/pnas.030540597
   PubMed Web of Science ®Google Scholar
• Streptomycin. (2008). Basic biology information. Tuberculosis, 88(2), 1652–1652. doi:10.1016/S1472-9792(08)70027-1
   Google Scholar
• Tripathi, S., Kumar, A., Kumar, B. S., Negi, A. S., & Sharma, A. (2015). Structural investigations into the binding mode of novel neolignans Cmp10 and Cmp19 microtubule stabilizers by in silico molecular docking, molecular dynamics, and binding free energy calculations. Journal of Biomolecular Structure and Dynamics, 34(6), 1232–1240. doi:10.1080/07391102.2015.1074941
   PubMed Web of Science ®Google Scholar
• Tseng, J. T., Bryan, L. E., & Van den Elzen, H. M. (1972). Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 2(3), 136–141.10.1128/AAC.2.3.136
   PubMed Web of Science ®Google Scholar
• Van Bambeke, F., Glupczynski, Y., Plésiat, P., Pechère, J. C., & Tulkens, P. M. (2003). Antibiotic efflux pumps in prokaryotic cells: Occurrence, impact on resistance and strategies for the future of antimicrobial therapy. The Journal of Antimicrobial Chemotherapy, 51(5), 1055–1065. doi:10.1093/jac/dkg224
   PubMed Web of Science ®Google Scholar
• van Westreenen, M., & Tiddens, H. A. W. M. (2010). New antimicrobial strategies in cystic fibrosis. Paediatric Drugs, 12(6), 343–352. doi:10.2165/11316240-000000000-00000
   PubMedGoogle Scholar
• Viveiros, M., Rodrigues, L., Martins, M., Couto, I., Spengler, G., Martins, A., & Amaral, L. (2010). Evaluation of efflux activity of bacteria by a semi-automated fluorometric system. Methods in Molecular Biology, 642, 159–172. doi:10.1007/978-1-60327-279-7_12
   PubMedGoogle Scholar
• Wang, Y., Chiu, J.-F., & He, Q.-Y. (2006). Proteomics approach to illustrate drug action mechanisms. Current Drug Discovery Technologies, 3(3), 199–209.10.2174/157016306780136763
   PubMedGoogle Scholar
• Wang, Y., Venter, H., & Ma, S. (2015). Efflux pump inhibitors: A novel approach to combat efflux-mediated drug resistance in bacteria. Current Drug Targets,.
   Web of Science ®Google Scholar
• Wenkert, E., Cochran, D. W., Gottlieb, H. E., Edward, W. H., Filhoa, R. B., Matos, F. J. D.A., & Madruga, M. I. L. M. (1976). W-NMR spectroscopy of naturally occurring substances. XLV. iboga alkaloids. Helvetica Cimica Acta, 59, 2437–2442.10.1002/(ISSN)1522-2675
   PubMed Web of Science ®Google Scholar
• Wiethoelter, A. K., Beltrán-Alcrudo, D., Kock, R., & Mor, S. M. (2015). Global trends in infectious diseases at the wildlife-livestock interface. Proceedings of the National Academy of Sciences of the United States of America, 112(31), 9662–9667. doi:10.1073/pnas.1422741112
   PubMed Web of Science ®Google Scholar